Updated:
ICN Holding
ICN HOLDING is an SEC-registered investment adviser in FREEHOLD, NJ. The firm manages $36 million in assets, $33 million on a discretionary basis.
ICN Holding
ICN HOLDING is an SEC-registered investment adviser in FREEHOLD, NJ. The firm manages $36 million in assets, $33 million on a discretionary basis. It has 6 employees and 1 investment adviser.
General information
Firm type
Single Family Office
Year founded
—
AUM
Greater than $5 billion (Altss estimate)
Location
Region
Europe
Country
Denmark
City
Freehold
Corporate office
Copenhagen, Denmark
Principals
Niels Peter Louis-Hansen
Chairman and controlling shareholder
Sector focus
Frequently asked questions
Who controls investment decisions at ICN Holding?
Niels Peter Louis-Hansen serves as chairman and controlling shareholder. He maintains direct oversight over major capital allocation decisions, supported by a small Copenhagen-based investment team. The governance structure concentrates authority at the family principal level, consistent with a single-family office model.
What was the wealth origin for the Louis-Hansen family?
The family's fortune was generated when Aage Louis-Hansen co-founded Coloplast in 1957. Coloplast grew into one of the world's largest medical-device manufacturers, specializing in ostomy, continence, and wound-care products. The family gradually sold down its stake over subsequent decades, recycling the proceeds into the industrial portfolio now held by ICN Holding.
Does ICN Holding manage outside capital or operate as a multi-family office?
No. ICN Holding functions strictly as a single-family office, investing only the Louis-Hansen family's own balance-sheet capital. The firm does not solicit or manage third-party funds, and reports no multi-family-office clients on any public registry.
How does ICN Holding source its private equity investments?
The firm relies on direct sourcing through a proprietary Nordic network built over decades of industrial ownership. ICN targets control positions in established, cash-flow-positive businesses, often through bilateral negotiations rather than competitive auctions. Its reputation as a permanent-capital buyer with multi-decade holding periods attracts founders and families seeking patient succession partners.
Is the Louis-Hansen family still dependent on Coloplast?
Niels Peter Louis-Hansen retains roughly 20% of Coloplast's voting rights, making the listed position a significant asset within the portfolio. However, the family's private holdings through ICN — spanning shipping, logistics, real estate, and industrial companies — now constitute a diversified asset base that substantially reduces reliance on the medical-device business.
Does ICN Holding maintain a separate philanthropic foundation?
Yes. The family's charitable giving is conducted through the Louis-Hansen Foundation, which is legally and operationally separate from ICN Holding. The foundation funds medical research, social welfare programs, and educational initiatives in Denmark. This separation mirrors the standard Nordic governance model for family-office philanthropy.
What is ICN Holding's position on co-investments with external institutional investors?
ICN Holding occasionally partners with institutional co-investors on large real-asset and infrastructure transactions, where syndicating risk or accessing specialized operating partners is advantageous. In corporate private equity, however, the firm strongly prefers sole ownership or majority control, valuing governance simplicity over co-investor capital.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: